The model (Figure 1 ) was used to capture the complex nature of obesity and its associated comorbidities over time. Patients could occupy a diabetes health state (either with T2DM, without T2DM or in T2DM remission), and transition between T2DM and remission on an ongoing basis. Patients could simultaneously occupy and transition between mutually exclusive health states (stroke, myocardial infarction [MI], cancer) as they progressed through the model. Prior to entering the Markov model structure, complication, reoperation and 30-day mortality rates due to surgery were allocated to the BMS cohort alongside associated costs and utilities. BMS and conventional treatment led to changes in BMI, blood pressure (BP), lipid ratio (LR) and rate of T2DM remission accordingly. BMI affected the probability of transitioning to T2DM. Age, sex, BP, LR and T2DM status affected the risk of stroke and MI, based on Framingham risk equations.[20] Patients could also experience knee pain and sleep apnea.

Model structure. Abbreviations: MI: myocardial infarction; T2DM: type 2 diabetes mellitus.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.